scholarly journals Adherence to European Society of Cardiology Heart Failure Treatment Guideline in Haji Adam Malik General Hospital Medan

2020 ◽  
Vol 3 (1) ◽  
pp. 59-64
Author(s):  
Ardy Putra Wirtanto ◽  
Andika Sitepu
Keyword(s):  
Heart Failure ◽  
European Society ◽  
Treatment Guidelines ◽  
Beta Blockers ◽  
Treatment Guideline ◽  
Public Health Problem ◽  
Cross Sectional ◽  
Heart Failure Treatment ◽  
Failure Treatment ◽  
European Society Of Cardiology

Background. Heart failure is a public health problem and the main cause of morbidity and mortality in the world. The goal of the therapy is to reduce symptoms, prevents rehospitalization and increases survivability. Objective. To evaluate the adherence to the European Society of Cardiology for heart failure treatment at H. Adam Malik Medan hospital. Methods. The study was descriptive observational cross sectional design with medical record data of heart failure at H. Adam Malik Hospital, using consecutive sampling method. The adherence of guidelines was assessed by: (1) drug prescribing (“yes” or “no”), and (2) guideline adherence indicator (GAI), both GAI-3 or GAI-5, by calculating the proportion as the number of drugs prescribed by number of drugs indicated to the ESC guidelines. Results. From research, the predominant GAI-3 and GAI-5 were High, which were 54.9% and 59.5%, respectively. The recommended drug used based on indications were ACE-i / ARB (89.1%), beta-blockers (83.4%), MRA (73.6%), diuretics (93.7%), and digitalis (20,8%). Conclusion. The predominant category in adherence to the ESC heart failure treatment guidelines based on GAI-3 and GAI-5 is High.

scholarly journals Clinical, paraclinical characteristics and real –world treatment of acute heart failure at Hanoi Heart Hospital

2021 ◽  
Vol 35 ◽  
pp. 233-242
Author(s):  
Vu Quynh Nga ◽  
Tran Thanh Hoa ◽  
Nguyen Van Son
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Treatment Guidelines ◽  
Artery Bypass ◽  
Severe Illness ◽  
Assisted Circulation ◽  
Heart Failure Treatment ◽  
Failure Treatment ◽  
Number Of Patients ◽  
Heart Hospital

Background: At Hanoi Heart Hospital, in recent years, along with the development of science and technology, the development of modern treatment measures such as percutaneous coronary intervention, coronary artery bypass surgery, heart valve replacement ... helped save the lives of many patients. However, these patients still require continued treatment for heart failure as a complication of the primary illness and thus also increase the number of patients with heart failure, both acute and decompensated. Objective: “Describe the clinical and subclinical characteristics of hospitalized patients with acute heart failure and the status of heart failure treatment according to current heart failure treatment guidelines at Hanoi Heart Hospital”. Method: Cross-sectional, prospective, descriptive analysis with convenient sample size. Results: From January 2018 to december 2018, 475 patients were hospitalized due to acute heart failure or decompensation ,63,8% male and 36, 2% female. Mean age 69,1 ± 13,8;  63,6% newly discovered heart failure; 41,4% EF 40 – 50% and 58,6% EF < 40%; number of Hopital days 8.3 ± 6.2 days(( 1- 46 days); there are five (1.1%) patients died in hospital; among them a patient who was treated for one day due to severe illness died; we have used interventions, assisted circulation and respiration such as CRT, CRT-D, CVVH, IABP, atrial septal defect and ECMO. Conclusion: Results of treatment of acute heart failure at Hanoi Heart Hospital is feasible with rate of discharge is 87,7%.

scholarly journals Trends in the pharmacological management of atrial fibrillation in UK general practice 2008–2018

Heart ◽  
2021 ◽  
pp. heartjnl-2021-319338
Author(s):  
Katherine Phillips ◽  
Anuradhaa Subramanian ◽  
G Neil Thomas ◽  
Nazish Khan ◽  
Joht Singh Chandan ◽  
...  
Keyword(s):  
Heart Failure ◽  
Atrial Fibrillation ◽  
Rate Control ◽  
Beta Blockers ◽  
Rhythm Control ◽  
Cross Sectional ◽  
Pharmacological Management ◽  
Stroke Outcomes ◽  
European Society Of Cardiology ◽  
The Uk

ObjectiveThe pharmacological management of atrial fibrillation (AF) comprises anticoagulation, for stroke prophylaxis, and rate or rhythm control drugs to alleviate symptoms and prevent heart failure. The aim of this study was to investigate trends in the proportion of patients with AF prescribed pharmacological therapies in the UK between 2008 and 2018.MethodsEleven sequential cross-sectional analyses were performed yearly from 2008 to 2018. Data were derived from an anonymised UK primary care database. Outcomes were the proportion of patients with AF prescribed anticoagulants, rhythm and rate control drugs in the whole cohort, those at high risk of stroke and those with coexisting heart failure.ResultsBetween 2008 and 2018, the proportion of patients prescribed anticoagulants increased from 45.3% (95% CI 45.0% to 45.7%) to 71.1% (95% CI 70.7% to 71.5%) driven by increased prescription of non-vitamin K antagonist anticoagulants. The proportion of patients prescribed rate control drugs remained constant between 2008 and 2018 (69.3% (95% CI 68.9% to 69.6%) to 71.6% (95% CI 71.2% to 71.9%)). The proportion of patients prescribed rhythm control therapy by general practitioners (GPs) decreased from 9.5% (95% CI 9.3% to 9.7%) to 5.4% (95% CI 5.2% to 5.6%).ConclusionsThere has been an increase in the proportion of patients with AF appropriately prescribed anticoagulants following National Institute for Health and Care Excellence and European Society of Cardiology guidelines, which correlates with improvements in mortality and stroke outcomes. Beta-blockers appear increasingly favoured over digoxin for rate control. There has been a steady decline in GP prescribing rates for rhythm control drugs, possibly related to concerns over efficacy and safety and increased availability of AF ablation.

scholarly journals Utilization of Beta-Blockers and Diuretics in Treating Heart Failure Patients in Sultan Qaboos University Hospital

2020 ◽  
Vol 2 (2) ◽  
Author(s):  
Tariq Dhiyab Al-Saadi ◽  
Al-Salt Al-Kharusi ◽  
Ali Abdulrahman
Keyword(s):  
Heart Failure ◽  
Beta Blockers ◽  
University Hospital ◽  
Cross Sectional ◽  
Care Clinic ◽  
Mortality And Morbidity ◽  
Sultan Qaboos University ◽  
Heart Failure Patients ◽  
High Prevalence ◽  
European Society Of Cardiology

Background: Heart failure (HF) is the inability of the heart to pump blood to meet tissue requirement of oxygen and nutrition, due to abnormality in cardiac structure or function. The mortality from congestive heart failure remain increasing along with aging of the population. In Oman, the prevalence of HF is 5.17 per 1000 people and with male and older age group domination. Beta-blockers and diuretics are well known drugs that decrease mortality and morbidity. According to heart failure treating guidelines beta-blockers are the first line treatment for HF. Since HF has a high prevalence, this study aim was to determine the utilization of beta-blockers and diuretics in treating heart failure patients in Sultan Qaboos University Hospital (SQUH). Methods: A retrospective cross-sectional conducted in SQUH, in cardiology day care clinic in the period from 1st of June until 30th of August. This study included all Omani patients with 120 out of 778 patients were included who were above 18 years old, diagnosed with HF, receiving at least one HF medication from SQUH pharmacy, and did not have any missing data. Hospital electronic medical record was used to obtain patients data and parameters. Results: Out of 120 patients, 54.2% were males and 45.8% were females, with mean age equal to 64 ± 13 years and mean EF equal to 37 ± 14.5 %. Diuretics were taken by 95% of the patients, where beta-blockers were taken by 81.6%. Prescription of beta-blockers was significantly decreased by increase in the age of the patients (p =0.024), while diuretics do not show any significant with change in the age. Both beta-blockers and diuretics do not show any significant increase or decrease in prescription with change in the EF. Bisoprolol was not affected by increase in age or EF. The prescription of carvedilol was significantly affected with increase the age (p = 0.006), however it was not affected by increase the EF. The prescription of spironolactone was significantly affected by increase the age (P= 0.001) and by increase the EF (P = 0.001). Conclusion: Carvedilol and furosemide were the most prescribed drugs in SQUH for treating HF patients. All the mean daily doses of the drugs mentioned in this study followed the newer 2016 European Society of Cardiology Guidelines for the diagnosis and treatment of acute and chronic HF.

scholarly journals Adherence to the ESC Heart Failure Treatment Guidelines in Spain: ESC Heart Failure Long-term Registry

2015 ◽  
Vol 68 (9) ◽  
pp. 785-793
Author(s):  
María G. Crespo-Leiro ◽  
Javier Segovia-Cubero ◽  
José González-Costello ◽  
Antoni Bayes-Genis ◽  
Silvia López-Fernández ◽  
...  
Keyword(s):  
Heart Failure ◽  
Treatment Guidelines ◽  
Heart Failure Treatment ◽  
Failure Treatment

scholarly journals Beta-blockers in chronic heart failure in elderly patient

2009 ◽  
Vol 3 (2) ◽  
pp. 89-95
Author(s):  
Alberto De Bernardi
Keyword(s):  
Heart Failure ◽  
Elderly Patient ◽  
Chronic Heart Failure ◽  
Elderly Patients ◽  
Observational Studies ◽  
Randomized Trials ◽  
Beta Blockers ◽  
Young Patients ◽  
Heart Failure Treatment ◽  
Failure Treatment

Chronic heart failure (CHF) is a common and disabling condition with morbidity and mortality that increase dramatically with advancing age. There are evidences, from both randomized trials and observational studies, that suggest that beta-blockers are effective and well tolerated in elderly as well as in young patients. Nonetheless in clinical practice they are substantially underutilized in elderly patients. The article underlines peculiarities of chronic heart failure treatment with beta-blockers in elderly patients, with a review of the most important published trials.

Sign in / Sign up

Export Citation Format

Share Document